Updates & background
Articles on
cannabis medicine.
Articles on legal framework, cost coverage, treatment options and practice knowledge, edited by the canmed association. We sell nothing; we help you make sense of things.
-
Medical cannabis in Switzerland: what the law change of 1 August 2022 actually changed
Since 1 August 2022, physicians in Switzerland may prescribe cannabis medicines without an FOPH exemption permit. What this means in legal, organisational and patient-facing terms, with sources from the Federal Office of Public Health (FOPH) and Swissmedic.
-
GMP, GACP and the Pharmacopoeia, explained simply
Why pharmaceutical quality is more than 'cleanly grown': a look at the three Swiss frameworks that sit behind every medical cannabis flower and every magistral preparation, from cultivation practice to the pharmacopoeia monograph.
-
What is medical cannabis, really?
Flowers, extracts, oils, magistral preparations and authorised medicines: an overview of the dosage forms dispensed on prescription in Switzerland, and the legal and practical difference between a formula magistralis and an authorised finished product.
-
What Swiss research knows about medical cannabis
Between patient surveys at UZH's ISGF, fundamental research at ETH and the national MeCanna reporting system: an overview of the main Swiss research and data sources on cannabis medicines.
-
Street cannabis vs. pharmacy cannabis
What sets illegally traded cannabis apart from pharmaceutical-grade cannabis flowers dispensed by a Swiss pharmacy? A sober comparison of active-substance content, contaminants, standardisation, advice and legal certainty.
-
Health insurance and medical cannabis in 2026
When Swiss health insurers cover the cost of cannabis-based treatment, what belongs in a coverage request, and which active substances are currently on the specialities list.